claimgotdeniedAnalyze

Xolair (omalizumab) prior authorization denied appeal

Anti-IgE for allergic asthma, CIU, nasal polyps, food allergy

To appeal a denied prior authorization for Xolair (omalizumab), file a written appeal within 180 days. The appeal must cite the insurer's clinical policy, include a letter of medical necessity from the prescriber, and document each criterion the policy requires. The most common winning evidence is documented prior therapy history and a specialist letter.

Typical PA criteria

  • Approved indication with ICD-10
  • For asthma: total IgE 30–1500 IU/mL and positive aeroallergen sensitivity
  • For CIU: inadequate response to H1 antihistamines
  • Specialist prescriber (allergy/immunology or pulmonology)

Why your PA was denied

  • IgE level outside 30–1500 IU/mL window
  • Aeroallergen sensitivity not documented
  • H1 antihistamine trial not documented for CIU
  • Non-specialist prescriber

Evidence that overturns the denial

  • ✓Total IgE result within labeled range
  • ✓Positive skin prick or specific IgE (aeroallergen)
  • ✓ACT or CIU severity score
  • ✓Prior H1 antihistamine trial documentation

Dose is weight- and IgE-based; PA form requires body weight and IgE. Food-allergy indication added 2024.

Draft a Xolair (omalizumab) appeal letter

Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.

Draft my appeal letter

FAQ

Why was my Xolair (omalizumab) prior authorization denied?+

The most common reasons are: IgE level outside 30–1500 IU/mL window; Aeroallergen sensitivity not documented; H1 antihistamine trial not documented for CIU. Your denial letter names the specific criteria you did not meet.

How do I appeal a Xolair (omalizumab) denial?+

File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.

What evidence overturns a Xolair (omalizumab) denial?+

Total IgE result within labeled range; Positive skin prick or specific IgE (aeroallergen); ACT or CIU severity score.

What if the plan excludes Xolair (omalizumab) entirely?+

Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.

Other drugs

Keep reading

Not legal or medical advice. This page is a self-help resource. You make your own decisions. Strip personal identifiers (name, date of birth, address, member ID) from any document before uploading or sharing. The information here summarizes commonly-published payer policies and federal rules; confirm against your specific plan document and the current denial letter before acting.